iomeprol has been researched along with Anemia, Hemolytic, Autoimmune in 1 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
Anemia, Hemolytic, Autoimmune: Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mayer, B | 1 |
| Leo, A | 1 |
| Herziger, A | 1 |
| Houben, P | 1 |
| Schemmer, P | 1 |
| Salama, A | 1 |
1 other study available for iomeprol and Anemia, Hemolytic, Autoimmune
| Article | Year |
|---|---|
Intravascular immune hemolysis caused by the contrast medium iomeprol.
Topics: Adult; Anemia, Hemolytic, Autoimmune; Complement C3d; Contrast Media; Coombs Test; Female; Humans; I | 2013 |